Company

Quentis Therapeutics, Inc.

Quentis Therapeutics is a New York biotechnology company developing targeted cancer therapies.

About

Quentis Therapeutics, Inc. is a biotechnology company headquartered in New York, US, founded in 2016. It develops cancer therapies, with a focus on targeted treatments, for healthcare providers, research institutions and pharmaceutical companies. The company raised USD 48.00 mn in Series A funding on February 27, 2018, with investment from AbbVie Biotech Ventures and Polaris Partners.

1Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in